Session Information
2011 Midyear Clinical Meeting
Click here to go to the previous page
Antithrombotic Therapeutic Pearls and Debates 2011: New Insights into a New World
Track: Education Sessions (CE)
Program Code: 211-L01
Date: Monday, December 5, 2011
Time: 2:00 PM to 4:30 PM EST
Location: Auditorium C, Mid Level
PRESENTER(S):   Click the plus sign to see more detailed information about each speaker.
 William Dager, PharmD, FCSHP, Pharmacist Specialist, University of California, Davis Medical Center
Paul Dobesh
 Michael Gulseth, Program Director for Anticoagulation Services, Sanford USD Medical Center
Dr. Edith Nutescu, PharmD, FCCP, Clinical Associate Professor and Director, Antithrombosis Center, University of Illinois at Chicago, College of Pharmacy
PROGRAM CHAIR:   Click the plus sign to see more detailed information about each speaker.
 Michael Gulseth, Program Director for Anticoagulation Services, Sanford USD Medical Center

  • Describe the advantages and disadvantages of using the novel oral anticoagulants to prevent stroke due to atrial fibrillation in comparison to warfarin.
  • Develop strategies to assure the safe use of novel oral anticoagulants during the perioperative period.
  • Explain what is currently known about the use of the novel oral agents in the special populations of obesity and renal dysfunction.
  • Summarize the current evidence of dabigatran etexilate and rivaroxaban for the indication of prophylaxis of venous-thromboembolism (VTE).


Audio Synchronized to PowerPoint
(Code: 211-L01)
Attendee:Free
  
This session is a part of:
Handout Online
(Code: 211-L01)
Attendee: Free
  
This session is a part of: